• The FactorFirst card has been revised

    The highly popular and useful FactorFirst card has been revised and the new version is now available for orders! Thank you to a great team...

  • Important CHS survey on gene therapy

    Companies will likely make submissions to Health Canada for approval of gene therapies for hemophilia A and B in the next 6-12 months. To best...

  • CHS Board of Directors

    Meet the CHS Board of Directors! From left to right: First row: Cyril Boulila, Wendy Quinn, Leanne Owen. Back row: Dr. Lawrence Jardine, Derek Klatt,...

  • The CHS appoints new CEO

    CLICK HERE to read the official announcement from CHS President, Wendy Quinn.

  • 2021 CHS Annual Report

    Please CLICK HERE to access the 2021 CHS Annual Report. Should you want to consult the complete Financial Statements, you can do so by clicking...